Background: Mindfulness-based interventions may offer a promising approach for promoting psychological and physical health and wellbeing for patients with heart failure. However, the effects of mindfulness-based interventions for this population have not been systematically reviewed. Aims: This review aimed to synthesise available evidence to assess the effects of mindfulness-based interventions on psychological and physical outcomes and health-related quality of life in patients with heart failure. Methods: Seven English and two Chinese electronic databases were searched with keywords from inception to May 2019. Experimental studies that examined mindfulness-based interventions in adults with heart failure were eligible for inclusion. Two reviewers independently performed study selection, data extraction and study quality assessment. The results were then narratively synthesised. Results: This review identified five studies involving 467 patients with heart failure. The reviewed studies had weak to moderate quality. There were consistent findings that mindfulness-based interventions could significantly reduce depression (three studies) and anxiety (two studies) and improve health-related quality of life (two studies) after intervention. However, the effects on physical symptoms were inconsistent in three studies. The effects on physical function were only measured in one study, with non-significant changes being reported. Conclusions: This review provides preliminary evidence that mindfulness-based interventions are beneficial for patients with heart failure in reducing depression and anxiety and enhancing health-related quality of life in the short term. These findings should be carefully generalised considering the methodological limitations across studies. More rigorous studies are required to examine further the effects of mindfulness-based interventions in patients with heart failure.
Introduction
Heart failure (HF) is a complex clinical syndrome with typical symptoms and signs of reduced cardiac output and/or elevated intracardiac pressures due to structural and/or functional cardiac abnormalities. 1 HF has become a global public health priority due to its high prevalence and negative consequences such as high rates of hospitalisation and mortality and the huge economic and social burden on patients, families and healthcare systems. [2] [3] [4] [5] Moreover, the number Effects of mindfulness-based interventions on health-related outcomes for patients with heart failure: a systematic review of people living with HF is predicted to increase steeply due to the aging population and improved survival. 6 Patients with HF suffer distressing physical symptoms (e.g. breathlessness, fatigue and dizziness) and impaired functional status, which may worsen as the disease progresses. 2 In addition, symptoms of psychological distress such as depression and anxiety are very common among patients with HF, with a prevalence of 10-79% for depression and 9-53% for anxiety. 7 The presence of physical and psychological distress significantly impaired patients' health-related quality of life (HRQoL) and increased the risk of adverse clinical outcomes (e.g. emergency department visits, hospitalisations and mortality) and healthcare consumption. 7, 8 Despite advances in medical treatment, it could not fully address physical and psychological suffering and there is still a high prevalence of physical and psychological symptoms in this population. 8 Thus, patients need further support or complementary treatment and care in addition to medical treatment.
Conventional interventions such as self-care education, 9 lifestyle modification 10 and exercise training 11 have shown favourable effects on physical outcomes and HRQoL, but they rarely focused on the psychological distress of patients with HF. Furthermore, a systematic review suggested that common psychological interventions, such as motivational interviewing and supportive counselling, had non-significant effects on anxiety and physical function and mixed effects on depression in patients with HF. 12 Therefore, further effective strategies are required to improve both the physical and psychological health of patients with HF.
Mindfulness-based interventions (MBIs), as a 'third wave' of psychotherapy, 13 have recently been proposed as an approach for improving psychological and physical health. 14 Mindfulness refers to 'paying attention in a particular way: on purpose in the present moment and non-judgmentally'. 15 MBIs combine mindfulness practice (e.g. body scan and mindful meditation) and cognitive techniques to help people foster the awareness, attention and acceptance towards present moment experience (e.g. thoughts, emotional reactions and sensations) and thereby enhance the self-regulation of psychological and physical distress. 16 Numerous MBI programmes have been developed, such as mindfulness-based stress reduction (MBSR) 17 and mindfulness-based cognitive therapy (MBCT), 18 which are most widely applied and examined in different settings.
Several systematic reviews have established the effectiveness of MBIs in improving psychological and physical health and HRQoL in a variety of clinical populations, such as patients with stroke, 19 diabetes 20 and cancer. 21 Experimental studies have also shown that MBIs significantly reduced anxiety and depression and improved physical function and HRQoL in patients with heart diseases. 22, 23 Moreover, increasing evidence suggests great promise that MBIs may yield a feasible and effective way to improve psychological and physical health as well as HRQoL for patients with HF. 24, 25 However, MBI programmes for patients with HF have not been systematically evaluated, and the existence of methodology flaws such as small sample size and lack of randomisation in individual studies 24, 25 may threaten the validity and reliability of the findings. Thus, the aim of this review was to synthesise available evidence to evaluate the effects of MBIs on psychological and physical outcomes and HRQoL in patients with HF.
Methods

Search strategies
A systematic search was conducted by reviewing seven English electronic databases (Medline via Ovid, Embase, PsychINFO, Cochrane Library, CINAHL Complete, PubMed and Web of Science) and two Chinese electronic databases (China Journal Net and WanFang Data) from inception to May 2019, without restriction on publication date or language. Keywords and medical subject headings (MeSH) of 'mindfulnes', 'mindful* ' , or 'meditation' were adopted in combination with 'heart failure' or 'cardiac failure'. A sample search strategy for the Medline via Ovid database is illustrated in Supplementary Appendix A. The reference lists of related articles were also hand-searched to identify any additional studies.
Eligibility criteria
Inclusion criteria included: (a) all experimental trials including randomised controlled trials (RCTs) and quasi-experimental designs; (b) participants were adult patients with a diagnosis of HF; (c) trials studied MBIs as a stand-alone intervention or as a primary part of a multicomponent intervention without restriction of intervention dose, format or follow-up period; and (d) trials assessed the effects of MBIs on any of the following outcomes: psychological outcomes (e.g. anxiety and depression), physical outcomes (e.g. physical symptoms and physical function) and HRQoL. For the purpose of this review, MBIs were defined as standardised intervention programmes such as MBSR and MBCT, and slight adaptions (e.g. shortened or amended versions) of standardised programmes. Exclusion criteria included: (a) studies not providing sufficient information about intervention contents, outcomes and results to permit an accurate judgement of intervention effects for patients with HF; and (b) studies without full text, protocols, reviews, conference abstracts, clinical guidelines or editorials.
Study selection
The retrieved records were merged and duplicates were removed using RefWorks. Then two reviewers independently screened the titles and abstracts of the records. The full texts of potentially eligible studies were retrieved and further assessed for eligibility. Any disagreements on eligibility were discussed and solved by consultation with a third independent researcher.
Data extraction
Data extraction was performed by the principal reviewer and verified by the second reviewer. Data on author, publication year, study design, details of participants (sample size, age and gender), intervention and control groups, details of MBIs (types, contents, doses and delivery formats), outcome measures and major results were extracted and integrated using a matrix table.
Methodological quality assessment
The quality of included studies was appraised by two reviewers independently using the quality assessment tool for quantitative studies developed by the effective public health practice project (EPHPP; see Supplementary Appendix B). 26 This tool allows reviewers to rate the study quality in six dimensions (selection bias, study design, confounders, blinding, data collection methods and withdrawals and dropouts) as strong, moderate or weak. An overall judgement of study quality can be given based on the ratings of the six dimensions. This tool can be applied to various quantitative study designs and has demonstrated good validity and reliability. 27 Any disagreements between the two reviewers were discussed and resolved by consulting an independent researcher.
Data synthesis
Due to insufficient data and considerable clinical and methodological heterogeneity across the studies, it was inappropriate to perform a meta-analysis. We therefore synthesised the findings of the effects of MBIs using a narrative summary approach.
Results
Results of the search
The searching and selection process is presented in Figure 1 . Our search strategy identified a total of 487 records. After removing duplications, the number of records was reduced to 294, out of which 280 records were excluded by reviewing titles and abstracts. The remaining 14 records were retrieved for full text and further screened for eligibility. Nine articles were excluded for the following reasons: two enrolled participants with other diseases; four did not discuss MBIs or did not employ MBIs as a primary intervention component; two reported insufficient information on the intervention; and one provided insufficient information for group comparison. Finally, five studies, including three from English databases 24, 25, 28 and two from Chinese databases, 29, 30 were included.
Study characteristics
The reviewed studies were published in 2018 24,28-30 and 2009 25 and were conducted in China, 29, 30 the United States 25, 28 and Sweden. 24 A total of 467 patients with HF were involved in this review. Sample sizes ranged from 11 28 to 208, 25 with three studies involving fewer than 60 participants. 24, 28, 29 The mean age of participants varied from 60.9 28 to 76 years 24 and the proportion of male patients ranged from 27.3% 28 to 70%. 25 Two studies employed an RCT design, 29, 30 two used a controlled clinical trial (CCT) design 24, 25 and one utilised a single group pre-test and post-test (cohort) design. 28 Except for the single group pre-test and post-test study, 28 the other studies utilised usual care as a comparison. 24, 25, 29, 30 One study demonstrated a long-lasting intervention effect over 12 months' follow-up, 25 while the other studies only reported effects at the completion of intervention. 24, [28] [29] [30] More detailed characteristics of the included studies are summarised in Table 1 . Table 2 presents details of the quality of included studies. Three studies were rated as moderate [28] [29] [30] and two as weak 24, 25 for overall quality. As for selection bias, one study was judged as weak because some participants were self-referred 25 and the other four studies were judged as moderate as participants were not randomly selected or the selection method and process were not reported. 24, [28] [29] [30] All studies were rated as weak in terms of blinding, as it was not possible to blind participants given the nature of intervention and blinding of assessors was unclear or not achieved. All studies were rated as strong in domains of study design, confounders, data collection methods and withdrawals and dropouts, except for one which was rated as moderate in the study design domain because it used a single group pre-test and post-test design, 28 one was rated as weak in the confounders domain due to not adjusting relevant confounders, 25 and one was rated as weak in the data collection methods domain because it did not report the reliability and validity of data collection tools. 24 
Quality of included studies
Description of interventions
MBI served as a stand-alone intervention in four studies 24,28-30 and as a major part of a multicomponent intervention in the remaining study. 25 The interventions in reviewed studies were adapted from MBSR, 25, 29, 30 MBSR and MBCT, 24 and mindful self-compassion (MSC). 28 MBSR, 17 MBCT 18 and MSC 31 are structured MBI programmes which commonly involve eight weekly sessions of 2-2.5 hours of mindfulness training. The identified MBIs in this review comprised similar intervention components, including the introduction of mindfulness techniques, mindfulness practice (e.g. body scan, breathing practice and sitting meditation) and discussion of practice experience. However, the intervention doses of reviewed studies varied largely from three intensive sessions within 9 days 29 to 12 weekly 90-minute sessions. 28 Besides, all studies asked participants to practice mindfulness daily beyond intervention sessions. Four studies reported that interventions were delivered in group-based formats 24, 25 or individual-based formats. 28, 29 All interventions were facilitated by nurses or other healthcare professionals who were qualified or trained as mindfulness instructors. In addition, three studies reported that interventions were provided according to their respective intervention manuals to facilitate intervention fidelity. 24, 25, 28 Effects of MBIs Psychological outcomes. Three studies examined the effects of MBIs on depression and reported consistent findings that interventions significantly reduced depression at the completion of intervention (all P<0.05). 25, 28, 30 Moreover, one study reported a sustained intervention effect on reducing depression at 3 months (P=0.013) and 6 months (P=0.007) after intervention, 25 but the overall effect over 12 months' follow-up was non-significant. Depression was assessed with different instruments in each study, namely the patient health questionnaire-9 (PHQ-9), 28 self-rating depression scale (SDS), 30 and Center of Epidemiology-depression scale (CES-D). 25 All instruments have been proved valid and reliable with the Cronbach α coefficients for PHQ-9, SDS and CES-D of 0.85, 32 0.90 33 and 0.842, 34 respectively.
Two studies examined and reported significant reductions in anxiety after receiving mindfulness training (all P<0.05). 25, 30 Moreover, one study reported a sustained reduction in anxiety over 12 months' follow-up (P=0.003), 25 suggesting the sustainable effects of MBI on anxiety. Anxiety was measured with the self-rating anxiety scale (SAS) 30 and the tension-anxiety subscale of the profile of mood states (POMS). 25 Both instruments have satisfactory reliability and validity and the Cronbach α coefficients were 0.834 for SAS 35 In addition to the focus on psychological distress, the included studies also revealed the benefits of MBIs in other psychological outcomes, including significant improvement in subjective happiness (P<0.001) 30 and reduction of perceived control (P=0.02) 28 and self-perceived burden (P<0.001). 29 Physical outcomes. Three studies examined the effects of MBIs on HF symptoms but reported inconsistent findings. Two studies measured the severity of general HF symptoms (e.g. fatigue and breathlessness) and revealed significant reductions after intervention (all P<0.05). 25, 28 One of the two studies also found a sustained decrease in general symptoms over 12 months' follow-up (P=0.024). 25 However, another study measured specific HF symptoms separately and reported significant reductions in fatigue (P=0.0165) and unsteadiness/dizziness (P=0.039) but a non-significant change in breathlessness (P=0.123) and tiredness (P=0.436). 24 The former two studies assessed general HF symptoms using the symptoms subscale of the Kansas City cardiomyopathy questionnaire (KCCQ) 25 and symptom status questionnaire-heart failure (SSQ-HF). 28 The third study measured fatigue, unsteadiness/dizziness and breathlessness and tiredness using the fatigue severity scale (FSS), a numerical rating scale and a five-point Likert scale, respectively. 24 KCCQ is reliable and valid in evaluating disease-specific health status in different domains; the Cronbach α for the symptoms domain was 0.78. 37 The reliability and validity of SSQ-HF have also been supported in patients with HF with the Cronbach α of 0.80. 38 FSS has demonstrated good psychometric properties in chronic conditions but has not been examined in the HF population. 39 However, the reliability and validity of the numerical rating scale and the five-point Likert scale were not reported by this reviewed study nor in previous articles, which may lead to measurement bias.
Only a single study assessed the effects of MBIs on physical function, including walking distance in the 6-minute walk test (6MWT), heart rate (HR) and respiratory rate (RR). 24 However, there is no significant change in 6MWT (P=0.112), HR (P=0.289) or RR (P=0.559) between groups after intervention. The 6MWT has been widely used to evaluate physical function and has been reported with good test-retest reliability (intra-class correlation coefficient of 0.90) and validity in patients with HF. 40 The failure to detect significant effects of MBI may due to the small sample size (n=40) or lack of effective intervention components to promote physical function.
Health-related quality of life. Two studies measured and reported significant improvements in HRQoL after intervention. 25, 28 One study also observed significant improvements in HRQoL over 12 months' follow-up (P=0.033), 25 suggesting sustained favourable effects on HRQoL. The summary score of KCCQ 25 and the Minnesota living with heart failure questionnaire (MLHFQ) 28 were used to measure disease-specific HRQoL. KCCQ and MLHFQ have been widely used and demonstrated excellent reliability and validity. The Cronbach α coefficients were 0.95 for KCCQ 37 and 0.90 or above for MLHFQ. 41
Discussion
To the best of our knowledge, this is the first review to synthesise available evidence regarding the effects of MBIs for patients with HF. MBIs for patients with HF are relatively rare as only five recently published experimental studies were identified. The majority of included interventions were adapted from MBSR with similar intervention contents, but the intervention doses and delivery formats varied across studies. Despite considerable clinical and methodological heterogeneity across reviewed studies, this review suggests that MBIs might hold promise as an effective approach for promoting psychological health and HRQoL for patients with HF.
Depression and anxiety are common symptoms of psychological distress for patients with HF and are associated with reduced HRQoL and poor prognosis. 7, 42 This review demonstrates that MBIs may significantly reduce depression and anxiety at the completion of intervention and 3 and 6-month follow-up, which are in line with the findings of a systematic review of vascular disease 43 and RCTs in other heart diseases. 22, 44 The effects of MBIs on reducing psychological distress have been widely examined in a wide range The global quality of a study is rated as strong, moderate and weak if having no weak ratings, one weak rating and two or more weak ratings in six dimensions, respectively. of populations. A systematic review of RCTs provided further support that MBIs had mild to moderate effects on depression and anxiety for people with chronic conditions. 45 The effects of MBIs on HF symptoms were less conclusive due to inconsistent results. The reviewed studies showed that MBIs significantly reduced general HF symptoms 25, 28 and specific HF symptoms of fatigue and dizziness. 24 Consistently, RCTs have shown that MBIs significantly reduced disease-related physical symptoms among individuals with chronic disease, e.g. patients with fibromyalgia 46 or irritable bowel syndrome. 47 Nevertheless, one reviewed study reported non-significant effects of MBI on symptoms of breathlessness and tiredness, as measured by a five-point Likert scale. 24 A potential explanation is that the psychometric properties of the tool were unknown, which may be prone to measurement bias, and thus would lead to an incorrect estimate of the effect. 48 Future studies should measure targeted outcomes with valid and reliable instruments.
The evidence for the effects of MBIs on physical function for patients with HF is limited because of insufficient data from a single study. This study reported that MBI had nonsignificant effects on physical function as measured by the 6MWT, HR and RR in a sample of 40 patients. The failure to find significant effects of MBI on physical function may due to the small sample size which was probably underpowered to detect significant effects. Conversely, an RCT with a powered sample of 324 patients with heart diseases (ischaemic, valvular, congenital heart disease or cardiomyopathy) revealed favourable effects of MBI on improving walking distance in the 6MWT and reducing HR. 22 Another potential explanation is that MBIs alone might be insufficient to improve patients' physical function. In a study among patients with cardiovascular disease, MBI was combined with cardiac rehabilitation and generated significant benefits in reducing HR. 49 This provides initial support that more effective strategies to promote physical outcomes are required. Incorporating MBI with strategies targeting physical health such as exercise training 50 and lifestyle modification 51 might be more powerful in promoting both psychological and physical outcomes for patients with HF.
This review indicates that MBIs might have positive effects on HRQoL for patients with HF. This finding is supported by a systematic review in vascular disease 43 and one RCT in cardiac patients who underwent a percutaneous coronary intervention procedure. 52 This finding has significance because patients with HF have significant impairment in HRQoL due to multiple physical symptoms and reduced cardiac function that may progressively worsen along with the disease trajectory. 53 Patients with HF have reported a lower degree of HRQoL, as compared with those with other cardiac conditions or non-cardiac diseases. 54 Therefore, improving HRQoL of patients with HF is crucial and has been considered as an important aspect of cardiovascular care. MBIs appear to be an effective approach for enhancing HRQoL in patients with HF; however, more studies are warranted to enhance the appealing benefits.
With only one study reporting long-term follow-up measures, 25 it was impossible to reach a clear conclusion regarding the sustained effects of MBIs for patients with HF. Although one study demonstrated that MBIs tended to have long-lasting effects on anxiety, HF symptoms and HRQoL, the evidence of this finding might be weakened by employing a non-RCT design (allocation by geographical location) and not controlling for confounders which were unable to address potential bias. 25 The generalisability of the finding to a broader population was also limited, as this study only included patients with reduced ejection fraction (left ventricular ejection fraction ⩽40%) and some participants were self-referred.
This review was unable to explore the impact of intervention doses on outcomes because the reviewed studies rarely provided the degree of compliance with the intervention sessions and home practice. Further studies should carefully record and report this information to help understand the relationship between the degree of compliance and outcomes. However, this review shows evidence for the positive effects of a brief MBI which involves three intervention sessions within 9 days. 29 An RCT in cardiac patients reported consistent findings that a brief mindfulness training with three weekly 90-120 minutes sessions had significantly favourable effects on anxiety, depression and HRQoL. 52 Further support is provided by a meta-analysis which revealed significant benefits of brief MBI programmes (lasting less than 2 weeks) on negative affectivity outcomes, e.g. depression and anxiety. 55 Perhaps the brief MBI programmes may be more applicable for patients with HF, especially for those with impaired cardiac function and multiple symptoms. Thus, brief MBIs warrant greater research attention to strengthen the evidence for the effects.
Researchers have increasing interest in the mechanisms through which MBIs conduce to positive effects on health outcomes. The change in mindfulness has been proposed as an important mediator to explain the effects of MBIs and a meta-analysis review provided preliminary evidence for this pathway. 56 MBIs have been shown to help participants reduce negative thinking (e.g. worry and rumination) and enhance emotion regulation and formulate adaptive coping strategies, which may contribute to beneficial effects. 57, 58 In addition, MBIs may alter the stress-induced physiological response, such as buffering the hyperactivity of the sympathetic nervous system and hypothalamicpituitary-adrenal pathways, which collectively leads to inflammation, atherosclerosis and autonomic dysfunction that impair cardiovascular function and increase cardiovascular risks. 59 However, due to the lack of examination of any plausible pathways within the available studies, this review was unable to address the underlying mechanisms of MBIs for patients with HF. Therefore, further exploration of this area is required.
Limitations
Firstly, this review only identified five studies and the sample sizes of three studies were relatively small (n=11-60), which may be underpowered to detect the effects of MBIs accurately. Moreover, the poor methodological quality of the reviewed studies may weaken the evidence of findings. This highlights the fact that future studies need to employ rigorous designs such as RCTs with large sample sizes to enhance the evidence for the effectiveness of MBIs in patients with HF. Secondly, the exploration of the sustained effects of MBIs was prevented by the results from a relatively small sample, indicating that long-term follow-ups are warranted. Thirdly, the underlying mechanisms through which MBIs improve health outcome remain unclear and need to be examined further. Finally, although our search strategy was comprehensive, studies published outside mainstream journals or unpublished data might have been missed. Thus, the current review cannot rule out possible publication bias.
Conclusions
This review provides preliminary evidence for the effects of MBIs on reducing depression and anxiety and improving HRQoL in the short term for patients with HF. The effects on HF symptoms and physical function were less conclusive due to inconsistent results and insufficient data. The findings of this review need to be interpreted with caution considering the poor quality of the reviewed studies. More rigorous research with the provision of RCT designs, powered sample sizes, valid and sensitive measures and long-term follow-ups is required to explore the effects of MBIs among patients with HF. Future studies should consider assessing the level of mindfulness, which may help understand how MBIs contribute to significant benefits for patients with HF. 
Implications for practice
